Leticia

Desogestrel/Ethinylestradiol, the active ingredients in Leticia, are a combined oral contraceptive presented as an oral tablet for oral use. They are prescribed to prevent pregnancy and to help regulate the menstrual cycle in women of reproductive age.

GNH USA supplies Leticia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Leticia, a combined estrogen‑progestin oral contraceptive, acts on the hypothalamic‑pituitary‑ovarian axis to prevent pregnancy and stabilize menstrual bleeding.

- Prevention of pregnancy: provides reliable contraceptive protection when taken as directed. - Menstrual cycle regulation: helps achieve more predictable bleeding patterns and reduces dysmenorrhea.

Leticia may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset that often resolves with continued use. - Breast tenderness: temporary swelling or discomfort. - Headache: mild to moderate intensity. - Spotting or breakthrough bleeding: irregular bleeding between periods. - Mood changes: irritability or mild depressive symptoms. - Weight fluctuation: slight increase or decrease.

Serious or Rare Side Effects: - Thromboembolic events: deep‑vein thrombosis or pulmonary embolism. - Hypertension: significant rise in blood pressure. - Liver disorders: cholestatic jaundice or hepatic adenoma. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Visual disturbances: sudden loss of vision or blurred sight.

Before prescribing Leticia, clinicians should evaluate individual risk factors and counsel patients on safe use.

- Contraindicated in pregnancy: product is classified as pregnancy category X and must not be used. - Avoid in smokers over 35 years: increased risk of cardiovascular events. - Screen for history of thromboembolic disorders: use only if benefits outweigh risks. - Monitor blood pressure regularly: combined estrogen‑progestin can elevate BP. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Leticia can interact with several medication classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy. - Antiretroviral protease inhibitors (e.g., ritonavir): may increase hormone levels, raising side‑effect risk. - St. John’s wort: decreases hormone levels, increasing chance of unintended pregnancy.

Moderate Interactions (Monitor Closely): - Antibiotics such as rifampin: may lower effectiveness; consider backup contraception. - SSRIs (e.g., fluoxetine): may heighten mood‑related side effects. - Diuretics (e.g., thiazides): may affect fluid balance and blood pressure, requiring monitoring.